Business Description
Description
Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics. It is developing a product for the treatment of fungal nail infections.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.73 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 14.9 | |||||
| 3-Year EPS without NRI Growth Rate | 5 | |||||
| 3-Year FCF Growth Rate | 17.5 | |||||
| 3-Year Book Growth Rate | -54.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.36 | |||||
| 9-Day RSI | 35.37 | |||||
| 14-Day RSI | 38.8 | |||||
| 6-1 Month Momentum % | 6.67 | |||||
| 12-1 Month Momentum % | -95.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.68 | |||||
| Quick Ratio | 3.68 | |||||
| Cash Ratio | 2.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.8 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -130.39 | |||||
| ROA % | -72.57 | |||||
| ROIC % | -1295.48 | |||||
| ROC (Joel Greenblatt) % | -3033.61 | |||||
| ROCE % | -128.35 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.79 | |||||
| Price-to-Tangible-Book | 0.79 | |||||
| EV-to-EBIT | 0.97 | |||||
| EV-to-EBITDA | 0.98 | |||||
| EV-to-FCF | 1.03 | |||||
| Price-to-Net-Current-Asset-Value | 0.75 | |||||
| Price-to-Net-Cash | 1.5 | |||||
| Earnings Yield (Greenblatt) % | 103.09 |
How Hexima Ltd (ASX:HXL) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.046 | ||
| Beta | 0 | ||
| Volatility % | 117 | ||
| 14-Day RSI | 38.8 | ||
| 14-Day ATR (A$) | 0.000687 | ||
| 20-Day SMA (A$) | 0.01555 | ||
| 12-1 Month Momentum % | -95.29 | ||
| 52-Week Range (A$) | 0.0105 - 0.415 | ||
| Shares Outstanding (Mil) | 167.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hexima Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hexima Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hexima Ltd Frequently Asked Questions
What is Hexima Ltd(ASX:HXL)'s stock price today?
The current price of ASX:HXL is A$0.02. The 52 week high of ASX:HXL is A$0.42 and 52 week low is A$0.01.
When is next earnings date of Hexima Ltd(ASX:HXL)?
The next earnings date of Hexima Ltd(ASX:HXL) is .
Does Hexima Ltd(ASX:HXL) pay dividends? If so, how much?
Hexima Ltd(ASX:HXL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
